Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.055
+0.035 (3.43%)
At close: Nov 21, 2025, 4:00 PM EST
1.069
+0.014 (1.36%)
After-hours: Nov 21, 2025, 7:33 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $138.31 million as of November 21, 2025. Its market cap has increased by 171.43% in one year.
Market Cap
138.31M
Enterprise Value
114.27M
1-Year Change
171.43%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $138.31M, a decrease of -73.10%. That is a compound annual growth rate of -27.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 138.31M | 204.69% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |